Overview

Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate the effect of treatment with Micardis/MicardisPlus on blood pressure and its ability to reduce different indicated cardiovascular risk scores. The study will also evaluate the current antihypertensive treatment pattern in the daily practice among the patient population at increased cardiovascular risk.
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Telmisartan